ALZHEIMER'S DRUG DISCOVERY FOUNDATION
The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease. Our pioneering biomedical venture philanthropy approach allows us to invest in the most promising drug discovery and development programs around the world in both academic institutions and biopharmaceutical companies. Since our founding in 1998, the ADDF has invested nearly $100 million to support over 500 programs across 18 countries.
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Industry:
Biotechnology
Founded:
1998-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.alzdiscovery.org
Total Employee:
11+
Status:
Active
Contact:
+1 212 901 8000
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Amazon Mobile Non Scaleable Content Cloudflare Hosting Cloudflare JS CDN JS Contact Form 7 Pound Sterling Cloudflare CDN CloudFront
Similar Organizations
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-26 | RetiSpec | Alzheimer's Drug Discovery Foundation investment in Series A - RetiSpec | 13.8 M CAD |
| 2024-05-20 | Coya Therapeutics | Alzheimer's Drug Discovery Foundation investment in Post-IPO Equity - Coya Therapeutics | 5 M USD |
| 2024-03-07 | NeuroAge Therapeutics | Alzheimer's Drug Discovery Foundation investment in Grant - NeuroAge Therapeutics | 250 K USD |
| 2023-12-20 | Superfluid Dx | Alzheimer's Drug Discovery Foundation investment in Series A - Superfluid Dx | N/A |
| 2023-12-15 | GliaPharm | Alzheimer's Drug Discovery Foundation investment in Grant - GliaPharm | 4.2 M USD |
| 2023-10-24 | Imeka | Alzheimer's Drug Discovery Foundation investment in Grant - Imeka | N/A |
| 2023-10-09 | CuraSen Therapeutics | Alzheimer's Drug Discovery Foundation investment in Grant - CuraSen Therapeutics | 5.8 M USD |
| 2023-09-19 | BrainScope Company | Alzheimer's Drug Discovery Foundation investment in Series B - BrainScope Company | N/A |
| 2023-09-11 | APRINOIA Therapeutics | Alzheimer's Drug Discovery Foundation investment in Venture Round - APRINOIA Therapeutics | 4.4 M USD |
| 2023-08-18 | Astrocyte Pharmaceuticals | Alzheimer's Drug Discovery Foundation investment in Series B - Astrocyte Pharmaceuticals | 6 M USD |
Official Site Inspections
http://www.alzdiscovery.org Semrush global rank: 771.18 K Semrush visits lastest month: 38.9 K
- Host name: 162.243.184.10
- IP address: 162.243.184.10
- Location: Clifton United States
- Latitude: 40.8364
- Longitude: -74.1403
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07014
More informations about "Alzheimer's Drug Discovery Foundation"
Alzheimer's Drug Discovery Foundation - Wikipedia
The Alzheimer's Drug Discovery Foundation (ADDF) is a nonprofit organization founded in 1998 by co-chairmen Leonard A. Lauder and Ronald S. Lauder of the Estée Lauder Companies cosmetics family and led by Howard Fillit, a geriatrician and neuroscientist. The ADDF provides funding to scientists who are conducting promising, innovative Alzheimer's disease drug research worldwide. The ADDF funds early-stage research and early-phase clinical trials that might otherwise go unfu…See details»
2024 Annual Report | Alzheimer's Drug Discovery …
The level of progress we have seen in 2024 is truly unprecedented, and it is an honor to lead an organization that is transforming the landscape and bringing hope to those in need. For the first time in history, we have multiple effective …See details»
2023 Annual Report - Alzheimer's Drug Discovery Foundation
Each year, the ADDF awards the Melvin R. Goodes Prize for Excellence in Alzheimer’s Drug Development to a scientist whose cutting-edge work based on the biology of aging is making a …See details»
Alzheimer's Drug Discovery Foundation - LinkedIn
Alzheimer's Drug Discovery Foundation Research Services New York, NY 16,485 followers Alzheimer's Drug Discovery Foundation (ADDF) is the only charity solely focused on finding drugs for Alzheimer'sSee details»
Alzheimer's Drug Discovery Foundation - Health Research Alliance
Organization Overview www.alzdiscovery.org. The mission of the Alzheimer’s Drug Discovery Foundation (ADDF) is to accelerate drug discovery for Alzheimer’s disease, related dementias …See details»
Alzheimer's Drug Discovery Foundation - Crunchbase
Contact Email [email protected] Phone Number +1 212 901 8000 The Alzheimer’s Drug Discovery Foundation (ADDF) is the only public charity solely dedicated to finding effective drugs for Alzheimer’s disease.See details»
Alzheimer’s Drug Discovery Foundation (ADDF) | Devex
Learn more about Alzheimer’s Drug Discovery Foundation (ADDF)'s jobs, projects, latest news, contact information and geographical presence. More than 44 million people worldwide suffer …See details»
Alzheimer's Drug Discovery Foundation - ZoomInfo
Who is Alzheimer's Drug Discovery Foundation. The ADDF is a non-profit organization solely focused on funding the development of drugs for Alzheimer's, employing a venture …See details»
Alzheimer's Drug Discovery Foundation Information
Alzdiscovery.org; 1 781444XXXX; Geralyn LaNeve Director, Marketing and Communications at Alzheimer's Drug Discovery Foundation New York, NY, US View. 1 alzdiscovery.org; 5+ …See details»
ALS Funding Goals | Alzheimer's Drug Discovery Foundation
Dec 21, 2021 The Target ALS Innovation Ecosystem has revolutionized the field in just seven years through collaborations that have resulted in the first potential treatments since ALS was …See details»
Our Portfolio | Alzheimer's Drug Discovery Foundation
2025 Emory University. Thomas Kukar, PhD Development of a granulin biologic to treat progranulin deficient FTD. Funding Amount: $349,890 Organization Type: Academic/Nonprofit …See details»
Alzheimer's Disease Prevention | ADDF 2024 Annual Report
The six-month MIND-AD trial, led by ADDF board member and recipient of the 2022 Goodes Prize, Dr. Miia Kivipelto, builds upon the findings of her landmark FINGER trial, which …See details»
Alzheimer's Drug Treatments - ADDF 2023 Annual Report
This year, we have seen significant progress in the field, with breakthroughs for amyloid-targeting drugs like Leqembi and donanemab. At the ADDF, our focus is advancing novel drugs that can …See details»
Alzheimer’s Drug Discovery Foundation Chief Executive Officer …
Apr 24, 2025 The Alzheimer’s Drug Discovery Foundation (ADDF) announced today that Mark Roithmayr will retire from his role as Chief Executive Officer effective December 31, 2025. The …See details»
ADDF-Harrington Scholar Program | Alzheimer's Drug Discovery …
How well characterized is the animal model? Has it been characterized in the applicant’s or collaborator’s lab, or is there historical control data available from the contract research …See details»
Alzheimer's Drug Discovery Foundation | New York NY - Facebook
As we commemorate #WorldAlzheimersDay, we are proud to share the future of #Alzheimer 's research is bright. Much of our optimism derives from the incredible progress we've made in …See details»
ADDF Summit 2024 - Alzheimer's Drug Discovery Foundation
The Summit is an invite-only, full-day collaboration of scientists, academics, industry and government professionals, and other pioneers. The symposium seeks to convene and connect …See details»
healthresearchfunders.org | » Health research funding organizations
Organization: Alzheimer's Drug Discovery Foundation : Website: www.alzdiscovery.org: Country: United States (USA) Annual expenditures on health research (in million 2013 US dollars): …See details»
Rating for Alzheimers Drug Discovery Foundation - Charity …
WWW.ALZDISCOVERY.ORG. 57 W 57TH ST STE 904. NEW YORK NY 10019-2822. 212-901-8000. ... Simply enter the organization's name (Alzheimers Drug Discovery Foundation) or EIN …See details»
Mark Roithmayr Appointed First CEO Of Alzheimer's Drug ... - Patch
Jan 11, 2017 Founded in 1998 by Leonard A. Lauder and Ronald S. Lauder, the Alzheimer’s Drug Discovery Foundation (ADDF) is dedicated to rapidly accelerating the discovery of drugs …See details»